Wade DT - Search Results

1

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.

Wade DT, Makela P, Robson P, House H, Bateman C. Wade DT, et al. Mult Scler. 2004 Aug;10(4):434-41. doi: 10.1191/1352458504ms1082oa. Mult Scler. 2004. PMID: 15327042 Clinical Trial.

2

A comparison of two physiotherapy treatment approaches to improve walking in multiple sclerosis: a pilot randomized controlled study.

Lord SE, Wade DT, Halligan PW. Lord SE, et al. Among authors: wade dt. Clin Rehabil. 1998 Dec;12(6):477-86. doi: 10.1191/026921598675863454. Clin Rehabil. 1998. PMID: 9869251 Clinical Trial.

3

A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.

Wade DT, Young CA, Chaudhuri KR, Davidson DL. Wade DT, et al. J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):246-9. doi: 10.1136/jnnp.73.3.246. J Neurol Neurosurg Psychiatry. 2002. PMID: 12185153 Free PMC article. Clinical Trial.

4

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.

Wade DT, Robson P, House H, Makela P, Aram J. Wade DT, et al. Clin Rehabil. 2003 Feb;17(1):21-9. doi: 10.1191/0269215503cr581oa. Clin Rehabil. 2003. PMID: 12617376 Clinical Trial.

5

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis.

Wade DT, Makela PM, House H, Bateman C, Robson P. Wade DT, et al. Mult Scler. 2006 Oct;12(5):639-45. doi: 10.1177/1352458505070618. Mult Scler. 2006. PMID: 17086911 Clinical Trial.

6

Can aerobic treadmill training reduce the effort of walking and fatigue in people with multiple sclerosis: a pilot study.

Newman MA, Dawes H, van den Berg M, Wade DT, Burridge J, Izadi H. Newman MA, et al. Among authors: wade dt. Mult Scler. 2007 Jan;13(1):113-9. doi: 10.1177/1352458506071169. Mult Scler. 2007. PMID: 17294619 Clinical Trial.

7

Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis.

Wade DT, Collin C, Stott C, Duncombe P. Wade DT, et al. Mult Scler. 2010 Jun;16(6):707-14. doi: 10.1177/1352458510367462. Mult Scler. 2010. PMID: 20558502

8

Exercise for multiple sclerosis: a single-blind randomized trial comparing three exercise intensities.

Collett J, Dawes H, Meaney A, Sackley C, Barker K, Wade D, Izardi H, Bateman J, Duda J, Buckingham E. Collett J, et al. Mult Scler. 2011 May;17(5):594-603. doi: 10.1177/1352458510391836. Epub 2011 Jan 19. Mult Scler. 2011. PMID: 21247971 Free article. Clinical Trial.

9

Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough?

Wade D. Wade D. Expert Rev Neurother. 2012 Apr;12(4 Suppl):9-14. doi: 10.1586/ern.12.12. Expert Rev Neurother. 2012. PMID: 22509986 Review.

10

The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis.

Rossier P, van Erven S, Wade DT. Rossier P, et al. Among authors: wade dt. Eur J Neurol. 2000 Nov;7(6):741-4. doi: 10.1046/j.1468-1331.2000.00142.x. Eur J Neurol. 2000. PMID: 11136367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters